Dimitris Voliotis
SVP, Clinical Development, Zentalis Pharmaceuticals, Inc.
Companies
- Radiopharm Theranostics LtdChief Medical Officer May 6, 2026 to now1
- Zentalis Pharmaceuticals, Inc.SVP, Clinical Development Apr 3, 2020 to Feb 14, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Zentalis Pharmaceuticals, Inc. ZNTL15,978 shares3$35.7K at $2.23Feb 14, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 14, 2022Sold 67 shares at $50.75 of Zentalis Pharmaceuticals, Inc.3
- Feb 14, 2022Sold 534 shares at $50.16 of Zentalis Pharmaceuticals, Inc.3
- Feb 10, 2022Granted 10,329 shares of Zentalis Pharmaceuticals, Inc.3
- Jan 20, 2022Sold 1,657 shares at $61.21 of Zentalis Pharmaceuticals, Inc.4
- Jan 20, 2022Sold 8,343 shares at $60.52 of Zentalis Pharmaceuticals, Inc.4
- Jan 20, 2022Exercised options 10,000 shares at $18.00 of Zentalis Pharmaceuticals, Inc.4
- Jan 19, 2022Sold 555 shares at $62.24 of Zentalis Pharmaceuticals, Inc.4
- Jan 19, 2022Sold 1,556 shares at $61.51 of Zentalis Pharmaceuticals, Inc.4
- Jan 19, 2022Sold 7,889 shares at $60.55 of Zentalis Pharmaceuticals, Inc.4
- Jan 19, 2022Exercised options 10,000 shares at $18.00 of Zentalis Pharmaceuticals, Inc.4
- Jan 18, 2022Sold 1,300 shares at $64.66 of Zentalis Pharmaceuticals, Inc.4
- Jan 18, 2022Sold 1,997 shares at $63.48 of Zentalis Pharmaceuticals, Inc.4
- Jan 18, 2022Sold 3,294 shares at $62.34 of Zentalis Pharmaceuticals, Inc.4
- Jan 18, 2022Sold 3,409 shares at $61.70 of Zentalis Pharmaceuticals, Inc.4
- Jan 18, 2022Exercised options 10,000 shares at $18.00 of Zentalis Pharmaceuticals, Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 20, 2022